MAP2 antibody (AA 350-400)

Catalog No. ABIN350476

This Rabbit Polyclonal antibody specifically detects MAP2 in WB and IHC. It exhibits reactivity toward Mouse.

Quick Overview for MAP2 antibody (AA 350-400) (ABIN350476)

Target: MAP2 (Microtubule-Associated Protein 2 (MAP2))

Reactivity: Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MAP2 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Product Details anti-MAP2 Antibody

Binding Specificity: AA 350-400

Purpose: Rabbit antibody to MAP2

Specificity: Specific for MAP-2.

Cross-Reactivity: Mouse, Rat

Cross-Reactivity (Details): Other species not yet tested.

Purification: IgG

Immunogen: A synthetic peptide from AA 350-400 of mouse MAP2 conjugated to blue carrier protein was used as the antigen. The peptide is homologous in rat.

Isotype: IgG

Application Details

Application Notes: IHC WB. A working concentration of 10-50 μg,ml is recommended. The optimal concentration should be determined by the end user. Not yet tested in other applications.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Reconstitute in 500 µL of sterile water. Centrifuge to remove any insoluble material.

Handling Advice: Avoid freeze and thaw cycles.

Storage: 4 °C,-20 °C

Storage Comment: Maintain the lyophilised/reconstituted antibodies frozen at -20C for long term storage and refrigerated at 2-8C for a shorter term. When reconstituting glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.

Expiry Date: 12 months

Target Details for MAP2

Target: MAP2 (Microtubule-Associated Protein 2 (MAP2))

Alternative Name: MAP2

Background: Regulates and organizes microtubules, may serve as a scaffolding protein for neuromodulatory activities. FUNCTION: The exact function of MAP2 is unknown but MAPs may stabilize the microtubules against depolymerization. They also seem to have a stiffening effect on microtubules. SUBCELLULAR LOCATION: Cytoplasm cytoskeleton. DEVELOPMENTAL STAGE: Isoform MAP2C is expressed during embryonic brain development and until postanatal day 10. Isoform MAP2B is expressed throughout brain development.

UniProt: P15146